Omeprazole Biogaran (Omeprazole)

Omeprazole Biogaran belongs to the proton pump inhibitor class and is used to manage acid‑related gastrointestinal conditions.

• Gastroesophageal reflux disease (GERD): provides symptomatic relief by lowering stomach acidity.
• Peptic ulcer disease: promotes ulcer healing through acid suppression.
• Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

• Omeprazole Biogaran irreversibly inhibits the H+/K+ ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid production, it markedly reduces both basal and stimulated gastric acid secretion, leading to an increase in gastric pH and allowing mucosal healing in acid‑related disorders.

Common Side Effects

• Headache: mild to moderate intensity.
• Abdominal pain: discomfort in the upper abdomen.
• Nausea: occasional feeling of queasiness.
• Diarrhea: loose stools occurring intermittently.
• Constipation: reduced bowel movements.
• Flatulence: increased intestinal gas.

Serious or Rare Side Effects

• Severe allergic reactions: anaphylaxis, Stevens‑Johnson syndrome.
• Clostridium difficile infection: colitis associated with antibiotic use.
• Hypomagnesemia: low magnesium levels with prolonged therapy.
• Liver enzyme elevation: increased ALT/AST.
• Interstitial nephritis: inflammation of kidney tissue.
• Bone fractures: increased risk with long‑term use.

Before initiating therapy, consider the following precautions.

• Assess renal function: adjust use in severe renal impairment.
• Monitor magnesium levels: prolonged treatment may cause hypomagnesemia.
• Avoid long‑term use without supervision: risk of fractures and nutrient deficiencies.
• Use caution in liver disease: hepatic impairment may affect drug metabolism.
• Review concomitant medications: potential for clinically significant interactions.
• Store at room temperature: keep in the original container, protect from moisture.

Omeprazole Biogaran can affect the pharmacokinetics of several drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect.
• Atazanavir: decreased absorption and efficacy.
• HIV protease inhibitors (e.g., ritonavir): altered metabolism leading to increased toxicity.

Moderate Interactions (Monitor Closely)

• Digoxin: increased serum concentrations.
• Methotrexate: heightened risk of toxicity.
• Oral contraceptives: possible reduction in contraceptive effectiveness.